Cvs Health (CVS) EBIT Margin (2009 - 2026)

Cvs Health's EBIT Margin history runs 18 years deep, the most recent figure standing at 13.85% for Q1 2026.

• Quarterly EBIT Margin rose 1330.0% year-over-year to 13.85% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 3.45% (down 16.0% YoY) and the FY2025 annual result came in at 1.66%, down 63.0% from the prior year.
• EBIT Margin was 13.85% for Q1 2026 at Cvs Health, up from 0.37% in the prior quarter.
• Across five years, EBIT Margin topped out at 17.07% in Q4 2022 and bottomed at 18.66% in Q3 2022.
• A 5-year average of 3.27% and a median of 0.87% in 2024 frame the typical range for EBIT Margin.
• Annual changes were most pronounced in 2022 — EBIT Margin slumped 1899 bps — and 2023, when it soared 3362 bps.
• Cvs Health's EBIT Margin stood at 17.07% in 2022, then slumped by 99 bps to 0.09% in 2023, then surged by 7610 bps to 7.28% in 2024, then plunged by 105 bps to 0.37% in 2025, then soared by 3868 bps to 13.85% in 2026.
• Business Quant data shows CVS's EBIT Margin at 13.85% in Q1 2026, 0.37% in Q4 2025, and 3.12% in Q3 2025.